Mads A. Ropke
Ballerup, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Imaging-guided tape stripping reveals consistent stratum corneum profiling of disease severity and treatment-responsive molecular features in pediatric atopic dermatitis.
Journal: Journal of dermatological science
Published: July 22, 2025
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.
Journal: American journal of clinical dermatology
Published: March 07, 2025
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics.
Journal: Journal of clinical medicine
Published: December 20, 2024
Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 13, 2024
Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled study.
Journal: Allergy
Published: August 12, 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: April 29, 2022
Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis.
Journal: The British journal of dermatology
Published: April 18, 2022
Development and validation of a minimally invasive and image-guided tape stripping method to sample atopic skin in children.
Journal: Clinical and experimental dermatology
Published: March 25, 2022
IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro.
Journal: Allergy
Published: March 01, 2022
EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab.
Journal: The Journal of investigative dermatology
Published: February 11, 2022
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.
Journal: Journal of the American Academy of Dermatology
Published: December 11, 2020
Last Updated: 09/26/2026